GWAS |
- Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU) ( 24025145)
- Amyotrophic lateral sclerosis (sporadic) ( 24529757)
- Arterial stiffness (brachial-femoral pulse wave velocity) ( 32790701)
- Asthma (childhood onset) ( 27611488)
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885)
- Brain morphology (MOSTest) ( 32665545)
- Lead levels ( 26025379)
- Lung function (FEV1) ( 30061609)
- Lung function (FVC) ( 30061609)
- Monobrow ( 27182965)
- Neuritic plaque ( 31497858)
- Nose size ( 27182965)
- Parkinson's disease ( 26227905)
- Superior frontal gyrus grey matter volume ( 25335168)
- Systolic blood pressure ( 26969751)
- Thyroid volume in Hashimoto’s thyroiditis ( 32019955)
|
- Chronic lymphocytic leukemia (time to first treatment) ( 33510140)
- Hepcidin/ferritin ratio ( 27846281)
- Metabolite risk score for predicting weight gain ( 31560688)
- Myopia (pathological) ( 23049088)
- Normal facial asymmetry (angle of surface orientation score) ( 30631343)
- Obesity-related traits ( 23251661)
- Opioid dependence ( 31250797)
- Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) ( 29912962)
- Total body bone mineral density ( 29304378)
|